Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mack

Showing results (321-330 of 432) with videos related to

Pageof 44
Sort By:
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBDMatthew W Carroll, M Ellen Kuenzig, David R Mack, et al.
BMC Gastroenterology|May 18, 2022
Multimodal intervention to improve the transition of patients with inflammatory bowel disease from pediatric to adult care: protocol for a randomized controlled trialNatasha Bollegala, Melanie Barwick, Nancy Fu, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2008
IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine bindingGeorge M Buckley, Thomas A Ceska, Joanne L Fraser, et al.
Gastrointestinal Endoscopy|October 2, 2018
Clinical disease activity and endoscopic severity correlate poorly in children newly diagnosed with Crohn's diseaseNicholas Carman, Diane Tomalty, Peter C Church, et al.
Journal of Pediatric Gastroenterology and Nutrition|August 26, 2021
Early Change in Fecal Calprotectin Predicts One-Year Outcome in Children Newly Diagnosed With Ulcerative ColitisChenthan Krishnakumar, Ashwin N Ananthakrishnan, Brendan M Boyle, et al.
Hormones & Cancer|November 21, 2014
Statement of principleWilliam T Cefalu, K Sreekumaran Nair, Elizabeth R Seaquist, et al.
Endocrine Reviews|November 4, 2014
Statement of principleWilliam T Cefalu, K Sreekumaran Nair, Elizabeth R Seaquist, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2023
Natural protein engineering in the Ω-loop: the role of Y221 in ceftazidime and ceftolozane resistance in <i>Pseudomonas</i>-derived cephalosporinaseAndrew R Mack, Vijay Kumar, Magdalena A Taracila, et al.
Nature Communications|November 24, 2016
Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn's diseaseWalid Mottawea, Cheng-Kang Chiang, Marcus Mühlbauer, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2014
Statement of principleWilliam T Cefalu, K Sreekumaran Nair, Elizabeth R Seaquist, et al.
Pageof 44

Showing results (321-330 of 432) with videos related to

Sort By:
Pageof 44
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBDMatthew W Carroll, M Ellen Kuenzig, David R Mack, et al.
BMC Gastroenterology|May 18, 2022
Multimodal intervention to improve the transition of patients with inflammatory bowel disease from pediatric to adult care: protocol for a randomized controlled trialNatasha Bollegala, Melanie Barwick, Nancy Fu, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2008
IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine bindingGeorge M Buckley, Thomas A Ceska, Joanne L Fraser, et al.
Gastrointestinal Endoscopy|October 2, 2018
Clinical disease activity and endoscopic severity correlate poorly in children newly diagnosed with Crohn's diseaseNicholas Carman, Diane Tomalty, Peter C Church, et al.
Journal of Pediatric Gastroenterology and Nutrition|August 26, 2021
Early Change in Fecal Calprotectin Predicts One-Year Outcome in Children Newly Diagnosed With Ulcerative ColitisChenthan Krishnakumar, Ashwin N Ananthakrishnan, Brendan M Boyle, et al.
Hormones & Cancer|November 21, 2014
Statement of principleWilliam T Cefalu, K Sreekumaran Nair, Elizabeth R Seaquist, et al.
Endocrine Reviews|November 4, 2014
Statement of principleWilliam T Cefalu, K Sreekumaran Nair, Elizabeth R Seaquist, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2023
Natural protein engineering in the Ω-loop: the role of Y221 in ceftazidime and ceftolozane resistance in <i>Pseudomonas</i>-derived cephalosporinaseAndrew R Mack, Vijay Kumar, Magdalena A Taracila, et al.
Nature Communications|November 24, 2016
Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn's diseaseWalid Mottawea, Cheng-Kang Chiang, Marcus Mühlbauer, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2014
Statement of principleWilliam T Cefalu, K Sreekumaran Nair, Elizabeth R Seaquist, et al.
Pageof 44